A Trial of Polatuzumab Vedotin, Obinutuzumab and Glofitamab As a Peri-CAR-T Cell Treatment Strategy in Large B-cell Lymphoma
Clinical trial NCT06071871 · RECRUITING
Trial details
- NCT number
- NCT06071871
- Sponsor
- University College, London
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-16
- Primary completion
- 2027-07-30
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.